doi: 10.18632/oncotarget.8048 235 SamuelSMGhoshSMajeedYArunachalamGEmaraMMDingHet al
108 LeskeM
Cost and coverage have shifted meaningfully, and some older guidance is now wrong
Robb Bird, NMD FAARM Medical Director, Transformyou
The study groups (ALC+ Clomid and Clomid alone) were each about 400 women in size, so a very reasonably powered study
CrossRef hucMSCsEVsDerived 1433 Serves as a Bridge between YAP and Autophagy in Diabetic Kidney Disease Siqi Yin, Wanzhu Liu, Cheng Ji, Yuan Zhu, Yunjie Shan, Zixuan Zhou, Wenya Chen, Leilei Zhang, Zixuan Sun, Wenqin Zhou, Hui Qian, Chaoliang Tang Oxidative Medicine and Cellular Longevity.2022;[Epub] CrossRef Adenosine receptors as emerging therapeutic targets for diabetic kidney disease Eun Seon Pak, Jin Joo Cha, Dae Ryong Cha, Keizo Kanasaki, Hunjoo Ha Kidney Research and Clinical Practice.2022